Dimerix

Dimerix Gross Margin

The Gross Margin of Dimerix (DXB.AX) as of Oct 19, 2026 is 96.82 %. In the previous year, Gross Margin was 100.00 % — a change of -3.18% (lower).

Gross Margin

96.82 %

YoY

-3.18%

Last updated:

Gross Margin of Dimerix is 2026 96.82 % . Gross Margin of Dimerix was 2025 100.00 % . It decreases by -3.18% lower compared to the previous year.

For Dimerix, the gross margin of 96.8% is down versus 99.2% a few years ago.

The Dimerix Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
99.72 AUD
Jan 1, 2020
99.40 AUD
Jan 1, 2021
98.99 AUD
Jan 1, 2022
99.23 AUD
Jan 1, 2023
100.00 AUD
Jan 1, 2024
100.00 AUD
Jan 1, 2025
100.00 AUD
Jan 1, 2026
96.82 AUD
The Dimerix Gross Margin history
YEARGross MarginYoY
96.82 %-3.18%
100.00 %0.00%
100.00 %0.00%
100.00 %+0.78%
99.23 %+0.24%
98.99 %-0.42%
99.40 %-0.32%
99.72 %+0.49%
99.24 %-0.49%
99.73 %+0.04%
99.69 %-0.31%
100.00 %+32.96%
75.21 %-7,677.18%
-0.99 %-199.26%
1.00 %+71.20%
0.58 %-29.85%
0.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Gross Margin of Dimerix is 96.82 % in 2026.

Gross Margin of Dimerix changed from 100.00 % to 96.82 %, representing a -3.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Dimerix since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Dimerix with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Dimerix

All Key Metrics — Dimerix